Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Published in: Journal of Clinical Immunology 1/2013

01-01-2013 | Editorial

Preface: Immunological Tango in Barcelona 2011

Authors: Sudhir Gupta, Hans Peter Schwarz

Published in: Journal of Clinical Immunology | Special Issue 1/2013

Login to get access

Excerpt

In recent years there have been major developments in the understanding of the mechanisms of action of immunoglobulins and natural antibodies, and in the pathogenesis of a number of neurological diseases. Furthermore, there has been a renewed interest in one of the oldest cytokines, the migration inhibition factor (MIF), for its role in inflammation and cancer. These were among the topics discussed at the second International Forum on Immunoglobulin Research (IFIR) held in Barcelona, Spain, on September 14–17, 2011. Both IFIR and this supplement were sponsored by Baxter Healthcare Corporation. …
Metadata
Title
Preface: Immunological Tango in Barcelona 2011
Authors
Sudhir Gupta
Hans Peter Schwarz
Publication date
01-01-2013
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue Special Issue 1/2013
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-012-9753-5

Other articles of this Special Issue 1/2013

Journal of Clinical Immunology 1/2013 Go to the issue

OriginalPaper

MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity

OriginalPaper

Recurrent Respiratory Infections, Specific Antibody Deficiencies, and Memory B Cells

OriginalPaper

The Immunologic Functions of the Neonatal Fc Receptor for IgG

OriginalPaper

The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade

OriginalPaper

Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry

OriginalPaper

Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits